Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2645]

More patients with lung cancer could benefit from immunotherapy, study shows

More patients with lung cancer could benefit from immunotherapy, study shows

Afatinib a better choice for EGFR-mutated lung cancer in first-line

Afatinib a better choice for EGFR-mutated lung cancer in first-line

BAP1 mutation passed down over centuries and is associated with high incidence of several cancers

BAP1 mutation passed down over centuries and is associated with high incidence of several cancers

Talimogene laherparepvec approved for unresectable melanoma

Talimogene laherparepvec approved for unresectable melanoma

When cancer of unknown origin strikes, patient's family members face increased risk

When cancer of unknown origin strikes, patient's family members face increased risk

Younger age associated with increased likelihood of targetable genotype in lung cancer

Younger age associated with increased likelihood of targetable genotype in lung cancer

Newer cancer drug may help protect kidneys from damage caused by older drug

Newer cancer drug may help protect kidneys from damage caused by older drug

Study uncovers hard-to-detect cancer mutations

Study uncovers hard-to-detect cancer mutations

Scientists uncover process that could drive the majority of cancers

Scientists uncover process that could drive the majority of cancers

FDA granted accelerated approval to alectinib for patients with anaplastic lymphoma kinase - positive metastatic non-small cell lung cancer

FDA granted accelerated approval to alectinib for patients with anaplastic lymphoma kinase - positive metastatic...

More from ecancer